Clinical Trial Update: PET Imaging Study Using Evuzamitide to Detect Cardiac Amyloidosis in Patients With Inconclusive Nuclear Scans and Elevated TAD1 Levels

View source ↗

Summary

A PET imaging study using Evuzamitide to detect cardiac amyloidosis in patients with inconclusive nuclear scans and elevated TAD1 levels is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyloidogenic Transthyretin Amyloidosis
• Cardiac Amyloidosis

Drugs mentioned

• Evuzamitide

Snippet

Sponsor: Lorena Saelices | Conditions: Amyloidogenic Transthyretin (ATTR) Amyloidosis, Cardiac Amyloidosis | Status: NOT_YET_RECRUITING